What are the benefits of B-type natriuretic peptide in the early diagnosis and risk stratification of acute chest pain?
Research studies have shown that the use of B-type natriuretic peptide (BNP) can be beneficial in the early diagnosis and risk stratification of acute chest pain. Studies have found that BNP levels are higher in those with acute coronary syndromes, and thus can be used to differentiate between those with and without acute coronary syndromes. Additionally, research has shown that BNP levels can be used to predict mortality benefit from coronary revascularization in those with acute coronary syndromes. Finally, BNP can be used to provide dynamic risk stratification in those with acute coronary syndromes.